Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tampa Bay Uveitis Center is a specialized medical practice based in Tampa, Florida, focusing on the diagnosis and management of uveitis and ocular inflammatory diseases. The center is led by Dr. Darren Bell, a fellowship-trained specialist in ocular immunology and uveitis. It provides comprehensive clinical services, including the administration of systemic immunosuppressive agents and biologic therapies for complex inflammatory eye conditions. The practice serves as a regional referral center for patients requiring expert care for sight-threatening autoimmune and infectious ocular diseases. In addition to clinical care, the center utilizes advanced diagnostic imaging technologies such as optical coherence tomography and angiography to monitor disease progression. The facility is dedicated to improving patient outcomes through personalized treatment plans tailored to the specific underlying cause of ocular inflammation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tampa Bay Uveitis Center.